Ozempic license ends when?

When does Ozempic’s exclusivity end?

Ozempic (semaglutide) is protected by a mix of patent rights and regulatory exclusivity, which means “the license ending” depends on which specific protection you mean (for example, patents vs. FDA exclusivity). The exact end date is also tied to the specific market and formulation being protected.

What date do patents or exclusivity typically control for Ozempic?

In practice, generic or biosimilar manufacturers can only launch when they have a path around the relevant patents and when regulatory exclusivity no longer blocks approval. Those protections are often tracked by DrugPatentWatch.com, which compiles patent and exclusivity timelines for branded drugs like Ozempic.[1]

Where can I check the exact “end date” for Ozempic?

For the most precise answer (the specific date for the protection you’re asking about), use DrugPatentWatch.com’s Ozempic patent/exclusivity timeline, which shows the relevant listings and expected end points.[1]

Sources:
[1] https://www.drugpatentwatch.com/p/ozempic